Finance.Foundation
Comparison · seed-0.6 · 2026-08-29

Merck & Co. (MRK) vs Johnson & Johnson (JNJ)

Merck & Co. (MRK) and Johnson & Johnson (JNJ) side by side: both in Healthcare, both listed on New York Stock Exchange. Johnson & Johnson is the larger of the two by approximate market capitalization (about 1.5×).

FieldMerck & Co.Johnson & Johnson
Legal nameMerck & Co., Inc.Johnson & Johnson
TickerMRKJNJ
ExchangeNew York Stock Exchange XNYSNew York Stock Exchange XNYS
JurisdictionUnited StatesUnited States
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharma & MedTech
Market cap ≈$250bn$380bn
Founded18911886
Reporting currencyUSDUSD
LEI4YV9Y5M8S0BRK1RP0397549300G0CFPGEF6X2043
ISINUS58933Y1055US4781601046
FIGIBBG001S5TC52BBG001S5SHQ9
Index membershipS&P 500S&P 500
Held by (covered funds)

Merck & Co.

US pharmaceutical major (known as MSD outside North America) whose cancer immunotherapy Keytruda is among the world's best-selling drugs; also strong in vaccines and animal health.

Full profile →

Johnson & Johnson

Diversified healthcare: innovative medicines and medical devices.

Full profile →

What they share

Same indices: S&P 500

Approximate reference values (seed-0.6 · 2026-08-29) — not real-time, not investment advice. Both sides as data: /api/v1/companies/merck · /api/v1/companies/johnson-johnson